Pharama.Aero, a non-profit organization that aims to connect the life science and medical technology manufacturers to industry projects, recently launched a new initiative dubbed “Green Air Pharma Logistics Project with a focus on a green lane.” The project is being led by the Changi Airport Group with board liaisons from the Brussels Airport Company.

The purpose of the project is to help pharmaceutical manufacturers achieve sustainability and environmental goals to reduce their Scope 3 emissions (emissions not produced by the company itself or activities from assets controlled by the company). The initiative also aims to create more environmentally friendly and sustainable pharmaceutical products.

“Today, it is crystal clear that addressing sustainability challenges correctly is only possible through cross-industry collaborative initiatives. Pharma.Aero stands among the trendsetters shaping the industry’s path toward tangible solutions. We embarked on this project fully aware that it may take a few more years to achieve our envisioned goals,” said Frank Van Gelder, Secretary General of Pharma.Aero. “Through such projects, Pharma.Aero aims to foster a comprehensive understanding of the industry’s sustainability landscape and identify opportunities for collaboration and improvement. Our ultimate goal is to pave the way towards a greener future for pharmaceutical logistics.”

Findings from the Green Air Pharma Logistics Project will be presented in a technical report available online exclusively to Pharma.Aero partners and members after publications between December 2023 and January 2024.